Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Kimball

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
Environmental Health Perspectives|January 22, 1998
Effects of ozone and other pollutants on the pulmonary function of adult hikersS A Korrick, L M Neas, D W Dockery, et al.
Gigascience|July 28, 2025
Reducing skin microbiome exposure impacts through swine farm biosecurityIlya B Slizovskiy, Tara N Gaire, Peter M Ferm, et al.
Bioorganic & Medicinal Chemistry|October 1, 1993
1-Benzazepin-2-one calcium channel blockers--VI. Receptor-binding model and possible relationship to desmethoxyverapamilS D Kimball, J T Hunt, J C Barrish, et al.
Journal of Medicinal Chemistry|September 1, 1990
Dihydropyrimidine calcium channel blockers. 2. 3-substituted-4-aryl-1,4-dihydro-6-methyl-5-pyrimidinecarboxylic acid esters as potent mimics of dihydropyridinesK S Atwal, G C Rovnyak, S D Kimball, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|January 10, 2003
Oxidative activation of acylguanidine prodrugs: intestinal presystemic activation in rats limits absorption and can be inhibited by co-administration of ketoconazoleW G Humphreys, M T Obermeier, S Chong, et al.
Journal of Medicinal Chemistry|February 21, 1992
Benzazepinone calcium channel blockers. 2. Structure-activity and drug metabolism studies leading to potent antihypertensive agents. Comparison with benzothiazepinonesD M Floyd, S D Kimball, J Krapcho, et al.
Journal of Medicinal Chemistry|February 21, 1992
Benzazepinone calcium channel blockers. 3. Synthesis and structure-activity studies of 3-alkylbenzazepinonesJ Das, D M Floyd, S D Kimball, et al.
Molecular Pharmaceutics|May 16, 2023
Subclass Effects on Self-Association and Viscosity of Monoclonal Antibodies at High ConcentrationsAmjad A Chowdhury, Neha Manohar, Marta A Witek, et al.
Hypertension (Dallas, Tex. : 1979)|November 20, 2013
Neuron-specific (pro)renin receptor knockout prevents the development of salt-sensitive hypertensionWencheng Li, Hua Peng, Eamonn P Mehaffey, et al.
Molecular Pharmaceutics|October 2, 2023
Characterizing Protein-Protein Interactions and Viscosity of a Monoclonal Antibody from Low to High Concentration Using Small-Angle X-ray Scattering and Molecular Dynamics SimulationsAmjad A Chowdhury, Neha Manohar, Alfredo Lanzaro, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Environmental Health Perspectives|January 22, 1998
Effects of ozone and other pollutants on the pulmonary function of adult hikersS A Korrick, L M Neas, D W Dockery, et al.
Gigascience|July 28, 2025
Reducing skin microbiome exposure impacts through swine farm biosecurityIlya B Slizovskiy, Tara N Gaire, Peter M Ferm, et al.
Bioorganic & Medicinal Chemistry|October 1, 1993
1-Benzazepin-2-one calcium channel blockers--VI. Receptor-binding model and possible relationship to desmethoxyverapamilS D Kimball, J T Hunt, J C Barrish, et al.
Journal of Medicinal Chemistry|September 1, 1990
Dihydropyrimidine calcium channel blockers. 2. 3-substituted-4-aryl-1,4-dihydro-6-methyl-5-pyrimidinecarboxylic acid esters as potent mimics of dihydropyridinesK S Atwal, G C Rovnyak, S D Kimball, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|January 10, 2003
Oxidative activation of acylguanidine prodrugs: intestinal presystemic activation in rats limits absorption and can be inhibited by co-administration of ketoconazoleW G Humphreys, M T Obermeier, S Chong, et al.
Journal of Medicinal Chemistry|February 21, 1992
Benzazepinone calcium channel blockers. 2. Structure-activity and drug metabolism studies leading to potent antihypertensive agents. Comparison with benzothiazepinonesD M Floyd, S D Kimball, J Krapcho, et al.
Journal of Medicinal Chemistry|February 21, 1992
Benzazepinone calcium channel blockers. 3. Synthesis and structure-activity studies of 3-alkylbenzazepinonesJ Das, D M Floyd, S D Kimball, et al.
Molecular Pharmaceutics|May 16, 2023
Subclass Effects on Self-Association and Viscosity of Monoclonal Antibodies at High ConcentrationsAmjad A Chowdhury, Neha Manohar, Marta A Witek, et al.
Hypertension (Dallas, Tex. : 1979)|November 20, 2013
Neuron-specific (pro)renin receptor knockout prevents the development of salt-sensitive hypertensionWencheng Li, Hua Peng, Eamonn P Mehaffey, et al.
Molecular Pharmaceutics|October 2, 2023
Characterizing Protein-Protein Interactions and Viscosity of a Monoclonal Antibody from Low to High Concentration Using Small-Angle X-ray Scattering and Molecular Dynamics SimulationsAmjad A Chowdhury, Neha Manohar, Alfredo Lanzaro, et al.
Pageof 8